<figure><img src="image_1.png" /></figure>

HAL
open science

# Lentinan -triggered butyrate-producing bacteria drive the expulsion of the intestinal helminth *Trichinella spiralis* in mice

Xuemin Jin, Yi Liu, Isabelle Vallee, Gregory Karadjian, Mingyuan Liu, Xiaolei Liu

<figure><img src="image_2.png" /></figure>

## To cite this version:

Xuemin Jin, Yi Liu, Isabelle Vallee, Gregory Karadjian, Mingyuan Liu, et al.. Lentinan -triggered butyrate-producing bacteria drive the expulsion of the intestinal helminth *Trichinella spiralis* in mice. *Frontiers in Immunology*, 2022, 13, pp.926765. 10.3389/fimmu.2022.926765. anses-03750536

HAL Id: anses-03750536

https://anses.hal.science/anses-03750536

Submitted on 14 Sep 2023

HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d'enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

<figure><img src="image_3.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_4.png" /></figure>

OPEN ACCESS

EDITED BY
Lim Boon Huat,
Universiti Sains Malaysia (USM),
Malaysia

REVIEWED BY
Chiuhan Yee Leow,
Universiti Sains Malaysia (USM),
Malaysia
Luis Fonte,
Pedro Kouri National Institute of
Tropical Medicine (IPK), Cuba

*CORRESPONDENCE

Xiaolei Liu
liuxlei@163.com

†These authors have contributed
equally to this work

SPECIALTY SECTION

This article was submitted to
Parasite Immunology,
a section of the journal
Frontiers in Immunology

RECEIVED 23 April 2022

ACCEPTED 06 July 2022

PUBLISHED 28 July 2022

CITATION

Jin X, Liu Y, Vallee I, Karadjian G, Liu M and Liu X (2022) Lentinan -triggered butyrate-producing bacteria drive the expulsion of the intestinal helminth *Trichinella spiralis* in mice. *Front. Immunol.* 13:926765.
doi: 10.3389/fimmu.2022.926765

COPYRIGHT

© 2022 Jin, Liu, Vallee, Karadjian, Liu and Liu. This is an open-access article distributed under the terms of the **Creative Commons Attribution License** (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author (s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

# Lentinan -triggered butyrate-producing bacteria drive the expulsion of the intestinal helminth *Trichinella spiralis* in mice

Xuemin Jin<fnref n="1" />†, Yi Liu<fnref n="1" />†, Isabelle Vallee<fnref n="2" />, Gregory Karadjian<fnref n="2" />, Mingyuan Liu<fnref n="1" />,³ and Xiaolei Liu<fnref n="1" />*

Trichinellosis caused by *Trichinella spiralis* is a serious zoonosis with a worldwide distribution. Lentinan (LNT) is known to modulate the intestinal environment with noted health benefits, yet the effect of LNT against intestinal helminth is unknown. In our study, we first observed that LNT could trigger worm expulsion by promoting mucus layer functions through alteration of gut microbiota. LNT restored the abundance of *Bacteroidetes* and *Proteobacteria* altered by *T. spiralis* infection to the control group level. Interestingly, LNT triggered the production of butyrate. Then, we determined the deworming capacity of probiotics (butyrate-producing bacteria) in mice. Collectively, these findings indicated that LNT could modulate intestinal dysbiosis by *T. spiralis*, drive the expulsion of intestinal helminth and provided an easily implementable strategy to improve the host defence against *T. spiralis* infection.

KEYWORDS

*Trichinella spiralis*, lentinan, mucin, gut microbiota, butyrate

## Introduction

Helminths are a major global health problem. Trichinellosis, caused by *Trichinella spiralis*, brings huge morbidities to the host population (1). *T. spiralis* infects wild and domestic animals through contaminated pig meat, as the major source for *Trichinella* transmission, which has a negative impact on the pork meat market. Prevention of this disease by interrupting helminth transmission includes drug and vaccine development for livestock. In the early stages of infection, the host expels *T. spiralis* from the intestine

<footnote n="1">¹State Key Laboratory for Zoonotic Diseases, Key Laboratory for Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin University, Changchun, China,</footnote>

<footnote n="2">²UMR BIPAR, Anses, Ecole Nationale Vétérinaire d'Alfort, INRA, University Paris-Est, Animal Health Laboratory, Maisons-Alfort, France, ³Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, China</footnote>
through ‘weep’, leading to hyperplasia of goblet cells and increased production of mucin (the ‘weep’) (2), suggesting that priming of mucus production could have evolved to protect against helminth infection.

The mucus layer overlies the intestinal epithelium, known as the first barrier. Thickening of the mucus layer is a common feature of intestinal helminth infection (3). One significant feature of intestinal homeostasis is the host microbiota, which plays a critical role in supporting pathogen defense (2, 4) and may actually be necessary for host defence against parasites (5, 6). Interestingly, the presence of specific bacteria in the gut shapes the glycan profile of mucus (7), which mediates protection against pathogens (8). The potential value of microbiota in the development of new therapies for helminth infection has attracted much attention (9). We therefore hypothesized that changes in gut microbiota influence the ability of the host to expel helminth through mucus.

β-glucan from barley could trigger worm expulsion dependent on the gut microbiota (10). However, β-glucan from different sources may have different functions. Lentinan (LNT), another β-glucan, is extracted from mushroom (11). Previously, we showed the adjuvanticity of LNT against helminth *T. spiralis* infection (12). It has been reported that oral administration of polysaccharides such as LNT can be utilized by intestinal microbiota, thereby contributing to microbiota changes (13). Supplementation with LNT orally increased the expression levels of mucin and attenuated virus -induced intestinal damage in the host through intestinal microbiota and their metabolites (14). However, the effect of LNT against intestinal helminth infection is not completely understood and the role of LNT -induced gut microbiota remains elusive.

In the present study, we assessed the efficacy of LNT on helminth *Trichinella* infection in the intestine. We found that LNT could trigger worm expulsion by promoting mucus layer functions. Moreover, the deworming capacity of LNT was examined along with the effect on gut microbiota composition. And LNT failed to reduce the helminth burden in mice with gut microbiota-dysbiosis due to impairment of the mucus layer, suggesting that gut mircobiota composition contributed to LNT -triggered worm expulsion. The specific beneficial bacteria were analysed and the related metabolites were used to expel *T. spiralis* in the intestine.

# Materials and methods

## Ethics statement

C57BL/6J mice (female, 4-6 weeks old) were purchased from the Norman Bethune University of Medical Science (NBUMS), China. Female Wistar rats were purchased from the Experimental Animal Centre of College of Basic Medical Sciences, Jilin University

(Changchun, China) and kept in a temperature-controlled room (22 ± 2°C) under a 12 h dark-light cycle. All animal experiments were performed according to regulations of the Administration of Affairs Concerning Experimental Animals in China. The protocol was approved by the Institutional Animal Care and Use Committee of Jilin University.

## Helminths

The *T. spiralis* isolate (ISS534) was obtained from a naturally infected domestic pig in Henan Province in China. Briefly, Wistar rats were orally infected with 3000 infective larvae, and *T. spiralis* muscle larvae (ML) were recovered at 35 days post infection (dpi) (15).

## Lentinan administration experiment

To evaluate the role of type 2 immunity in the effect of LNT (MedChemExpress, HY-N6653) on *T. spiralis* infection, the mice were randomly divided into 5 groups (n = 6 per group): (1) the control (Con) group were untreated, (2) the group were infected with 500 ML, (3) the group were administrated orally with LNT (100 mg/kg) daily from -14 dpi to 7 dpi and infected with 500 ML, (4) the group were administrated with STAT6 inhibitor, AS1517499 (20 mg/kg i.p) at 1, 3 and 5 dpi and infected with 500 ML, (5) the group were administrated orally with LNT (100 mg/kg) daily from -14 dpi to 7 dpi, AS1517499 (20 mg/kg i.p) at 1, 3 and 5 dpi and infected with 500 ML.

To verify the role of microbiota in the effect of LNT on *T. spiralis* infection, the mice were randomly divided into 5 groups (n = 6 per group): (1) the control (Con) group were untreated, (2) the group were infected with 500 ML, (3) the group were administrated orally with antibiotics (ampicillin 1 g/L, vancomycin 0.25 g/L, neomycin 1 g/L, and metronidazole 1 g/L) daily 2 weeks before *T. spiralis* infection (500 ML), (4) the group were administrated orally with LNT (100 mg/kg) daily from -14 dpi to 7 dpi and infected with 500 ML, (5) the group were run in parallel with antibiotics and LNT daily 2 weeks before *T. spiralis* infection (500 ML) and LNT administration continued for 1 week after infection. The mice were sacrificed using CO₂ asphyxiation at 7 dpi and 35 dpi for collecting helminthes (intestinal adult worms and muscle larvae). Small intestine and content were immediately collected for the following experiment.

## Measurements of the small intestine mucus layers

Post Carnoy's fixation, the methanol-stored duodenum samples were embedded in paraffin, cut into thin sections (5
µm), and deposited on glass slides. Periodic acid Schiff (PAS) staining was performed according to standard protocols. Quantification of the goblet cell number was carried out by blinded operators. The sections were incubated with anti-mucin 2 (Muc2) rabbit polyclonal antibody (1:400 dilutions; Abcam) for immunohistochemistry according to kit manufacturer instructions. PAS and immunohistochemistry of Muc2 in duodenum. Scale bars: 50 µm.

## Real time PCR

mRNA expression of mucin 2 (Muc2) were quantified using RT-PCR using SYBR Green QPCR Master Mix (TaKaRa, Japan) with an Applied Bioscience 7500 thermocycler and FastStart Universal SYBR Green Master (Roche Applied Science, Germany) as described previously (16). Briefly, RNA extraction was performed by lysing 100 mg of small intestine tissue samples with Trizol reagent (Invitrogen). The primers of Muc2 were as follow: 5'- CCTTAGCCAAGGGCTCGGAA-3' and 5'- GGCCCGAGAGTAGACCTTGG-3' (17). The relative mRNA expression levels of the target genes were normalized to those of the indicated housekeeping gene (GAPDH) (5'-ACTCCACTCACGGCAAATTCT-3' and 5'-TCTCCATGGTGGTGAAGACA-3') and were quantified using the comparative Ct method and the formula $2^{-\Delta\Delta CT}$.

## Microbial analysis in small intestine contents

Genomic DNA amplification and sequencing were conducted. PCR amplification was performed as described previously (18). Briefly, microbial DNA was extracted from 100 mg of small intestine contents of mice under strict aseptic operation. Then DNA was stored at -80°C until further processing. The V3-V4 region of the bacterial 16S rRNA gene was amplified with the common primer pair (Forward primer, 5'- ACTCCTACGGG AGGCAGCA-3'; reverse primer, 5'- GGACTACHVG GGTWTCTAAT-3') combined with adapter sequences and barcode sequences. Microbiome sequencing data have been deposited at the National Center for Biotechnology Information, Sequence Read Archive (PRJNA723732).

The bioinformatics analysis of this study was performed with the aid of the BMK Cloud (Biomarker Technologies Co., Ltd., Beijing, China). We processed the raw data with Trimmomatic (v0.33) to trim low quality reads. Cutadapt was used to discard forward and reverse primers. The paired-end reads that were obtained were merged using FLASH v1.2.11 software, and reads with a length ≥400 pb were kept for the following analysis. The UCHIME algorithm (v8.1) was used in detecting and removing chimera sequences to obtain the clean tags. Sequences with similarity ≥97% were clustered into the same operational

taxonomic unit (OTU) by USEARCH (v10.0) (19), and the OTUs with reabundace <0.005% were filtered. Taxonomy was assigned to all OTUs by searching against the SILVA databases using the RDP classifier within QIIME2. The Alpha diversity and Beta diversity were calculated and displayed by the QIIME and R software, respectively. Furthermore, we employed Linear Discriminant Analysis (LDA) effect size (LEfSe). Based on the Kyoto Encyclopedia of Genes and Genomes (KEGG) functional pathway, the functional composition was prediceted for each sample using Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) (20). Statistical analyses were conducted with STAMP, and functional differences in orthologs among groups were assessed by a one way ANOVA followed by Tukey-Kramer multiple comparisons (21).

## Culture of Clostridium tyrobutyricum

*Clostridium tyrobutyricum* (*C. tyroburyicum*, ATCC25755) was purchased from ATCC. *C. tyroburyicum* were cultured in supplemented medium for 8 h, and the culture broth was centrifuged at 5000 ×g for 10 mins. The *C. tyrobutyricum* were suspended in sterile PBS. The culture supernatant of *C. tyrobutyricum* was collected and sterilized with a 0.22µmfilter.

## SCFAs concentrations assay

SCFA analysis was performed as described (22). Small intestine contents samples and *C. tyrobutyricum* culture supernatant were thawed, processed using vacuum distillation, and analyzed using gas chromatography on an Agilent 7890A GC system with an HP-INNO WAX column (30 m × 0.32 mm × 0.5 µm) and flame ionization detector (Agilent Technologies Inc., CA, USA). Results were reported as mmol/g according to the original weight of contents used, excluding their moisture values, as SCFAs are contained within the solid phase of the contents. All measurements were performed in triplicate.

## Sodium butyrate and Clostridium tyrobutyricum administration experiment

Sodium butyrate (SB) (Sigma Aldrich) was >97% high-performance liquid chromatography purity. SB (200 mg/kg) or *C. tyrobutyricum* (10⁸ CFU/200 µL PBS) was orally administered to mice daily from -14 dpi to 7 dpi and mice (n = 6 per group) were infected with 500 ML for establishing the acute infectious model. 6 mice per group were sacrificed using CO₂ asphyxiation at 7 dpi. Small intestine and content were immediately collected for the following experiment. Intestinal adult worms were collected at 7 dpi. The remaining mice (n=6 per group) were
sacrificed using CO₂ asphyxiation and ML were recovered and counted at 35 dpi.

## Statistical analysis

All results were expressed as the mean ± SD. N refers to the number of mice used. The data shown are representative of three independent experiments. Statistical differences were determined using a 2-tailed Student's t test or 1-way analysis of variance (Tukey honestly significant difference multiple comparison test) using GraphPad Prism (GraphPad Prism 8 Software, San Diego, CA). A P values are expressed as *p<0.05, **p<0.01 and ***p<0.001.

## Results

### Gut microbiota played a role in LNT – triggered expulsion of *T. spiralis*

To evaluate the role of type 2 immunity in the effect of LNT on *T. spiralis* infection, mice infected with *T. spiralis* were

administered a STAT6 inhibitor. We demonstrated that LNT significantly reduced the adult worm at 7 dpi and muscle larvae burden at 35 dpi. Interestingly, although inhibition of the IL-4 and IL-13 (type 2 cytokines) levels induced an increased burden of *T. spiralis*, we found that LNT still significantly reduced the burden of helminth (Figures S1A, B). Emerging evidence has revealed that the composition of intestinal microbiota is an important factor in regulating mucus barrier function in the intestine (7). To determine the role of gut microbiota in LNT-triggered host defence against *T. spiralis* infection, one group of mice administered an antibiotic treatment (AT) and LNT for comparison (Figure 1A). Adult worm and larvae burden were not significantly different in *T. spiralis*–infected mice with or without AT, however, the burden in mice with LNT + AT was significantly higher than the LNT alone group (Figures 1B, C), suggesting that the deworming capacity of LNT were impaired by AT. Moreover, mucus secretion was decreased in AT–induced gut microbiota-dysbiosis mice compared to the mice without AT. The expression of Muc2 induced by LNT was also significantly inhibited by AT (Figures 1D–F).

<figure><img src="image_5.png" /></figure>

<figure><img src="image_6.png" /></figure>

<figure><img src="image_7.png" /></figure>

<figure><img src="image_8.png" /></figure>

<figure><img src="image_9.png" /></figure>

<figure><img src="image_10.png" /></figure>

<figure><img src="image_11.png" /></figure>

<figure><img src="image_12.png" /></figure>

<figure><img src="image_13.png" /></figure>

<figure><img src="image_14.png" /></figure>

<figure><img src="image_15.png" /></figure>

<figure><img src="image_16.png" /></figure>

<figure><img src="image_17.png" /></figure>

<figure><img src="image_18.png" /></figure>

FIGURE 1

LNT failed to reduce the burden of *T. spiralis* in gut microbiota-dysbiosis mice. (A) Mice were administered an antibiotic treatment (AT) and LNT. (B) Adult worms (7 dpi) and (C) muscle larvae (35 dpi) were recovered from mice in each group, and the abundance of *T. spiralis* was calculated. (D) Periodic acid Schiff (PAS) staining (200×) of duodenal tissues (Scale bars: 50 µm). (E) Immunohistochemistry of duodenal tissues with anti-Muc2 antibody. (F) mRNA level of Muc2. Data are presented as the mean ± sd (n=6). The data shown are representative of three independent experiments. ns, not significant and ***p<0.001 as indicated by the line (one-way ANOVA with Tukey's post test). These figures are representative of three independent experiments.
## LNT administration shifted the gut microbiota in *T. spiralis*-infected mice

To investigate the effects of LNT on gut microbiota, 16S rRNA gene sequencing was performed. We showed that *T. spiralis* infection significantly decreased α-diversity in the Shannon index and Simpson index. The α-diversity was significantly increased in *T. spiralis* -infected mice with LNT administration (Figure 2A). A clear separation among the control group and *T. spiralis* group with or without LNT was found using UniFrac-based principal component analysis (PCoA) to evaluate the β-diversity (Figure 2B). *T. spiralis* infection significantly reduced the relative abundance of *Bacteroidetes* and enhanced *Proteobacteria* compared to controls (both p < 0.05), while LNT restored the abundance of *Clostridiales* and *Bacteroidales* to the control group level and significantly decreased the abundance of *Proteobacteria* compared to the *T. spiralis* group (Figures 2C-E). Linear discriminant analysis effect size (LEfSe) indicated that bacteria belonging to *Clostridia* and *Bacteroidia* were enriched in gut bacterial communities by LNT (LDA score >4) (Figure 3).

Notably, the amount of *Muribaculaceae* and *Lachnospiraceae* NK4A136 in LNT-fed mice was restored (Figure 3).

In level two KEGG pathways, 22 functional orthologs were altered significantly in the Ts group compared with the control group (Table 1). LNT was related to the obvious changes in microbial function among these functional orthologs, including cell motility, cellular community prokaryotes, transport and catabolism, metabolism of other amino acids, infectious diseases: parasitic, glycan biosynthesis and metabolism. Importantly, the abundance of functional genes related to parasitic infectious diseases increased in the *T. spiralis*-infected mice, but LNT could significantly decrease the abundance of these functional genes. In addition, LNT increased the functional genes related to glycan biosynthesis and metabolism compared to *T. spiralis*-infected mice.

## LNT increased the concentration of butyrate in *T. spiralis* -infected mice

SCFAs are associated with mucus in the intestine (7). It has also been observed that SCFAs, such as acetate and butyrate, stimulate

<figure><img src="image_19.png" /></figure>
A

<figure><img src="image_20.png" /></figure>

B

<figure><img src="image_21.png" /><figcaption>FIGURE 3
The most differentially significant abundant taxa enriched in microbiota by linear discriminant analysis (LDA). (A) Linear discriminant analysis (LDA) effect size showing the most differentially significant abundant taxa enriched in microbiota from the control group (Con), *T. spiralis* group (Ts), and *T. spiralis* + LNT group (TsLNT). (B) Heatmap of the abundance of bacteria at the genus level from the Con, Ts and TsLNT groups.</figcaption></figure>
<caption>TABLE 1 Predicted KEGG functional pathway differences at level 2 inferred from 16S rRNA gene sequences using PICRUSt during T. spiralis infection with or without LNT.</caption>

Functional categories

<table><thead><tr><th>Level 1</th><th>Level 2</th><th>Con:mean ± sd(%)</th><th>Ts:mean ± sd(%)</th><th>TsLNT:mean ± sd(%)</th><th>Con vs Ts p value</th><th>TsLNT vs Ts p value</th></tr></thead><tbody><tr><td rowspan="3">Cellular Processes</td><td>Cell motility</td><td>1.227±<br>0.251</td><td>0.173±<br>0.098</td><td>1.012±<br>0.271</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Cellular community -<br>prokaryotes</td><td>1.468±<br>0.079</td><td>1.183±<br>0.115</td><td>1.472±<br>0.032</td><td>0.001</td><td>0.002</td></tr><tr><td>Transport and catabolism</td><td>0.278±<br>0.07</td><td>0.138±<br>0.025</td><td>0.303±<br>0.038</td><td>0.005</td><td>&lt;0.001</td></tr><tr><td rowspan="2">Environmental Information<br>Processing</td><td>Signal transduction</td><td>2.772±<br>0.171</td><td>2.181±<br>0.127</td><td>2.691±<br>0.137</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Folding, sorting and degradation</td><td>1.586±<br>0.03</td><td>1.727±<br>0.06</td><td>1.573±<br>0.022</td><td>0.002</td><td>0.001</td></tr><tr><td rowspan="7">Human Diseases</td><td>Cancers: Overview</td><td>0.507±<br>0.025</td><td>0.686±<br>0.035</td><td>0.501±<br>0.01</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Drug resistance: Antimicrobial</td><td>1.01±<br>0.025</td><td>0.862±<br>0.039</td><td>1.023±<br>0.03</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td><strong>Infectious diseases: Parasitic</strong></td><td>0.022±<br>0.005</td><td>0.046±<br>0.007</td><td>0.037±<br>0.002</td><td>&lt;0.001</td><td>0.007</td></tr><tr><td>Cancers: Specific types</td><td>0.046±<br>0.007</td><td>0.177±<br>0.046</td><td>0.045±<br>0.003</td><td>0.001</td><td>0.001</td></tr><tr><td>Neurodegenerative diseases</td><td>0.132±<br>0.032</td><td>0.354±<br>0.166</td><td>0.114±<br>0.01</td><td>0.001</td><td>0.002</td></tr><tr><td>Infectious diseases: Viral</td><td>0.006±<br>0.006</td><td>0.044±<br>0.029</td><td>0.005±<br>0.002</td><td>0.027</td><td>0.034</td></tr><tr><td rowspan="10">Metabolism</td><td>Metabolism of other amino acids</td><td>1.333±<br>0.056</td><td>1.781±<br>0.052</td><td>1.37±<br>0.081</td><td>0.029</td><td>0.029</td></tr><tr><td>Metabolism of terpenoids and polyketides</td><td>1.07±<br>0.013</td><td>1.183±<br>0.017</td><td>1.054±<br>0.015</td><td>0.030</td><td>0.023</td></tr><tr><td>Xenobiotics biodegradation and metabolism</td><td>0.757±<br>0.081</td><td>1.34±<br>0.144</td><td>0.821±<br>0.088</td><td>0.032</td><td>0.031</td></tr><tr><td>Energy metabolism</td><td>3.852±<br>0.181</td><td>4.569±<br>0.189</td><td>3.839±<br>0.023</td><td>0.000</td><td>0.000</td></tr><tr><td>Biosynthesis of other secondary metabolites</td><td>1.038±<br>0.06</td><td>0.727±<br>0.104</td><td>1.062±<br>0.015</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Glycan biosynthesis and metabolism</td><td>1.558±<br>0.193</td><td>1.169±<br>0.024</td><td>1.611±<br>0.093</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Carbohydrate metabolism</td><td>10.04±<br>0.266</td><td>9.078±<br>0.541</td><td>10.15±<br>0.177</td><td>&lt;0.001</td><td>&lt;0.001</td></tr><tr><td>Nervous system</td><td>0.207±<br>0.009</td><td>0.124±<br>0.025</td><td>0.215±<br>0.008</td><td>&lt;0.001</td><td>0.001</td></tr><tr><td>Aging</td><td>0.282±<br>0.016</td><td>0.407±<br>0.057</td><td>0.272±<br>0.001</td><td>0.006</td><td>&lt;0.001</td></tr><tr><td rowspan="2">Organismal Systems</td><td>Immune system</td><td>0.077±<br>0.005</td><td>0.044±<br>0.017</td><td>0.079±<br>0.003</td><td>0.009</td><td>0.005</td></tr><tr><td>Circulatory system</td><td>0.004±<br>0.005</td><td>0.055±<br>0.04</td><td>0.001±<br>0.001</td><td>&lt;0.001</td><td>&lt;0.001</td></tr></tbody></table>

Muc2 expression in intestinal epithelial cells and increase mucus production and secretion (7). No statistically significant difference was observed in the concentrations of acetate and propionate between the Ts group and Ts+LNT group, whereas a significant decrease in the concentration of butyrate was noted (Figure 4A). In addition, the levels of butyrate in C. tyrobutyricum culture supernatant was shown in Figure 4B.

Sodium butyrate and Clostridium tyrobutyricum triggered the expulsion of T. spiralis

Butyrate is a primary product of gut microbial fermentation (23). C. tyrobutyricum is a probiotic, that is a butyrate-producing bacterium (24). To evaluate the effect of butyrate against T.
<figure><img src="image_22.png" /><figcaption>FIGURE 4</figcaption></figure>

Concentrations of short-chain fatty acids (SCFAs). SCFA analysis of (A) small intestine contents samples (n=6) and (B) *C. tyrobutyricum* culture supernatant (n=3) was performed. Data are presented as the mean ± sd. The data shown are representative of three independent experiments.
***p<0.001 as indicated by the line (one-way ANOVA with Tukey's post-test).

*spiralis* infection, mice were orally administered with SB or *C. tyrobutyricum* daily. Both SB and *C. tyrobutyricum* significantly decreased the burden of adult worms at 7 dpi and muscle larvae at 35 dpi in mice (Figures 5A, B). Consistently, SB and *C. tyrobutyricum* increased the numbers of goblet cells and promoted the secretion of mucus and Muc2 expression (Figure 5C-E).

Discussion

LNT has immunity-enhancing effects and we showed the adjuvanticity of LNT against helminth *T. spiralis* infection in the previous study (12). It has been reported that polysaccharides such as LNT can provide energy for gut microbiota in the intestine, and are associated with the homeostasis of the gut microbial community and overall host health (25). Intestinal dysbiosis participates in the pathogenesis of infections (26). In addition, LNT can ameliorate bacterial LPS -induced intestinal inflammation through gut microbiota (27). In this paper, we aimed to investigate the effect of oral LNT on helminth expulsion in vivo. We observed that an impaired type 2 immune response did not eliminate the capacity of worm expulsion by LNT; however, the gut microbiota contributed to LNT-triggered expulsion of helminth in the intestine by promoting the level of mucus. The intestinal mucus produced by goblet cells is a key player in the defense against enteric pathogens (2, 28). Increased goblet cell mucus secretion lead to alterations in the protective properties of the mucus barrier, which can directly or indirectly affect parasite establishment. It constitutes part of the “weep” response that develops to promote worm expulsion. Hyperplasia of goblet cells that produce mucin occurs in helminth infections, including *Trichinella spiralis*, *Trichuris muris*, and *Nippostrongylus brasiliensis* (29–31). Muc2 is the main source of mucin within the intestine and lack of Muc2 results in delayed expulsion of helminths in the intestine (32). Our results

demonstrated that LNT significantly elevated the expression of Muc2, suggesting that LNT promotes mucus production, thereby driving the expulsion of intestinal helminths.

The microbiome plays a major role in mucus changes (7). We demonstrated that LNT administration ameliorated the shift in gut microbiota composition induced by *T. spiralis* infection. The results of 16S rRNA gene sequencing analysis demonstrated that *T. spiralis* infection decreased the diversity of gut microbiota composition whereas LNT restored the abundance of *Bacteroidales* and *Clostridiales* to the control group level. Notably, the *Muribaculaceae* and *Lachnospiraceae* families were enriched in the gut bacterial communities restored by LNT. *Muribaculaceae* family was named as S24-7 at first. One genera of this family may be essential for glycan degradation (33), indicating that mucus production by LNT is enhanced, leading to an enriched *Muribaculaceae* family. Furthermore, *Lachnospiraceae* are a family of anaerobic bacteria in the *Clostridiales* order within the *Firmicutes* phylum, including species previously identified as *Clostridium* clusters (34) and accumulate near the mucosa, allowing them to affect the host epithelial and mucosal immune system (35). The *Lachnospiraceae* can promote the colonization resistance of microorganisms to pathogens through metabolites (36). *Lachnospiraceae* NK4A136 group involves in metabolic disease (37). The *Lachnospiraceae* family also affects enterocytes by producing SCFAs such as butyrate (38). It is indeed well known that 16S rRNA sequencing allows genus-level resolution at most, which is a limitation of this study, while shotgun metagenomics sequencing will provide more meaningful functional annotation data, which is worth investigating in the future. Interestingly, we consistently demonstrated that LNT significantly enhanced the levels of butyrate, indicating that this metabolite may drive expulsion function of *T. spiralis* in the intestine.

Other studies have demonstrated that gavaging probiotics enables mice to regain faster intestinal SCFA production (39), such as butyrate (40) and SCFAs are absorbed and used by
A

<figure><img src="image_23.png" /></figure>

B

<figure><img src="image_24.png" /></figure>

C

<figure><img src="image_25.png" /></figure>

D

<figure><img src="image_26.png" /></figure>

Ts

Ts + SB

Ts + C.t

E

<figure><img src="image_27.png" /></figure>

<figure><img src="image_28.png" /></figure>

<figure><img src="image_29.png" /><figcaption>FIGURE 5</figcaption></figure>

Sodium butyrate (SB) or Clostridium tyrobutyricum (C. t) reduced the burden of *T. spiralis* by promoting mucus production. SB (200 mg/kg) and C.t (10⁸ CFU/200 µL PBS) were orally administered to mice daily from -14 dpi to 7 dpi and mice (n = 6 per group) were infected with 500 ML to establish the acute infectious model. Six mice per group were sacrificed using CO₂ asphyxiation at 7 dpi. The remaining mice (n=6 per group) were sacrificed using CO₂ asphyxiation and ML were recovered and counted at 35 dpi. (A) Adult worms (7 dpi) and (B) muscle larvae (35 dpi) were recovered from mice in each group and the burden of *T. spiralis* was calculated. (C) mRNA level of Muc2. Data are presented as the mean ± sd (n=6). (D) Periodic acid Schiff (PAS) staining (200×) of duodenal tissues (Scale bars: 50 µm). (E) Immunohistochemistry of duodenal tissues with anti-Muc2 antibody. The data shown are representative of three independent experiments. ***p<0.001 as indicated by the line (Dunnett's multiple comparison following ANOVA). These figures are representative of three independent experiments.

colonocytes to recover part of the energy spent in the intensive
synthesis and secretion of mucus (41). Administration of
butyrate promotes clearance of intestinal pathogen
(Citrobacter rodentium) infection by enhancing mucus
secretion (42). C. tyrobutyricum resides in the gut and has a
protective role in defending against pathogens by regulating gut
microbiota metabolites, such as butyrate (43). We evaluated the
effect of butyrate and probiotics against helminth infection along
with the effect on the level of mucus. Our results showed that
butyrate and butyrate-producing bacteria could significantly

decrease helminth burden and promote the production of
mucus. Another study of ours found that barely β-Glucan-
triggered *Akkermansia muciniphila* expansion facilitates the
expulsion of intestinal helminth (10). Different sources of β-
glucan can affect different probiotics to play a role in deworming.
Therefore, targeted probiotics and related metabolite
intervention may restore a normal microenvironment for the
treatment or prevention of helminth infections.

In conclusion, these results first revealed that LNT could
promote mucus production and drive the expulsion of
<figure><img src="image_30.png" /><figcaption>FIGURE 6
Lentinan -triggered butyrate-producing bacteria drive the expulsion of the intestinal helminth *Trichinella spirali*.</figcaption></figure>

helminths. The butyrate-producing bacteria, *C. tyrobutyricum* also reduced the burden of helminths (Figure 6). Taken together, these findings of this study are easily implementable strategy to facilitate expulsion of gastrointestinal helminths.

## Data availability statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: NCBI, accession ID: PRJNA723732.

## Ethics statement

The animal study was reviewed and approved by Institutional Animal Care and Use Committee of Jilin University.

## Author contributions

XJ: Conceptualization, Writing- Original draft, Methodology, Software. YL: Data curation, Writing- Original draft, Methodology. IV: Visualization, Investigation, Methodology. GK: Writing- Reviewing and Editing. ML: Funding acquisition, Writing- Reviewing and Editing, Supervision. XL: Funding acquisition, Writing- Reviewing and Editing, Conceptualization, Supervision. All authors contributed to the article and approved the submitted version.

## Funding

This study was supported by the National Key Research and Development Program of China (2021YFC2600202); the

National Natural Science Foundation of China (31520103916, 31872467); Guangdong Innovative and Enterpreneurial Research Team Program (2014ZT05S123); Jilin Provincial Science and Technology Development Project (20180520042JH); and Program for JLU Science and Technology Innovative Research Team.

## Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

## Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

## Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2022.926765/full#supplementary-material
References

1. Robertson LJ. Parasites in food: from a neglected position to an emerging issue. *Adv Food Nutr Res* (2018) 86:71-113. doi: 10.1016/bs.afnr.2018.04.003

2. Coakley G, Harris NL. The intestinal epithelium at the forefront of host-helminth interactions. *Trends Parasitol* (2020) 36:761-72. doi: 10.1016/j.pt.2020.07.002

3. Grencis RK. Immunity to helminths: resistance, regulation, and susceptibility to gastrointestinal nematodes. *Annu Rev Immunol* (2015) 33:201-25. doi: 10.1146/annurev-immunol-032713-120218

4. Easton AV, Raciny-Aleman M, Liu V, Ruan E, Marier C, Heguy A, et al. Immune response and microbiota profiles during coinfection with plasmodium vivax and soil-transmitted helminths. *mBio* 11 (2020) 11(5):mBio.01705-20. doi: 10.1128/mBio.01705-20

5. Rausch S, Midha A, Kuhring M, Affinass N, Radonic A, Kuhl AA, et al. Parasitic nematodes exert antimicrobial activity and benefit from microbiota-driven support for host immune regulation. *Front Immunol* (2018) 9:2282. doi: 10.3389/fimmu.2018.02282

6. VanDussen KL, Funkhouser-Jones LJ, Akey ME, Schaefer DA, Ackman K, Riggs MW, et al. Neonatal mouse gut metabolites influence cryptosporidium parvum infection in intestinal epithelial cells. *mBio* 11 (2020) 11(6): pii: mBio.2582-20. doi: 10.1128/mBio.02582-20

7. Paone P, Cani PD. Mucus barrier, mucins and gut microbiota: the expected slimy partners? *Gut* (2020) 69:2232-43. doi: 10.1136/gutjnl-2020-322260

8. King KC, Brockhurst MA, Vasieva O, Paterson S, Betts A, Ford SA, et al. Rapid evolution of microbe-mediated protection against pathogens in a worm host. *ISME J* (2016) 10:1915-24. doi: 10.1038/ismej.2015.259

9. Hogan G, Walker S, Turnbull F, Curiao T, Morrison AA, Flores Y, et al. Microbiome analysis as a platform R&D tool for parasitic nematode disease management. *ISME J* (2019) 13:2664-80. doi: 10.1038/s41396-019-0462-4

10. Jin X, Liu Y, Wang J, Wang X, Tang B, Liu M, et al. Beta-glucan-triggered akkermansia muciniphila expansion facilitates the expulsion of intestinal helminth *via* TLR2 in mice. *Carbohydr Polym* (2022) 275:118719. doi: 10.1016/j.carbpol.2021.118719

11. Jong SC, Birmingham JM. Medicinal and therapeutic value of the shitake mushroom. *Adv Appl Microbiol* (1993) 39:153-84. doi: 10.1016/S0065-2164(08)70595-1

12. Jin X, Liu X, Ding J, Zhang L, Yang Y, Wang X, et al. Lentinan improved the efficacy of vaccine against trichinella spiralis in an nlrp3 dependent manner. *PLoS Negl Trop Dis* 14 (2020) 14(9):e0008632. doi: 10.1371/journal.pntd.0008632

13. Wang X, Wang W, Wang L, Yu C, Zhang G, Zhu H, et al. Lentinan modulates intestinal microbiota and enhances barrier integrity in a piglet model challenged with lipopolysaccharide. *Food Funct* (2019) 10:479-89. doi: 10.1039/C8FO02438C

14. Mao X, Hu H, Xiao X, Chen D, Yu B, He J, et al. Lentinan administration relieves gut barrier dysfunction induced by rotavirus in a weaned piglet model. *Food Funct* (2019) 10:2094-101. doi: 10.1039/C8FO001764F

15. Jiang P, Wang ZQ, Cui J, Zhang X. Comparison of artificial digestion and baermann's methods for detection of trichinella spiralis pre-encapsulated larvae in muscles with low-level infections. *Foodborne Pathog Dis* (2012) 9:27-31. doi: 10.1089/fpd.2011.0985

16. Jin X, Yang Y, Bai X, Shi H, Zhang W, Zhang Z, et al. Dendritic cells treated by trichinella spiralis muscle larval excretory/secretory products alleviate TNBS-induced colitis in mice. *Int Immunopharmacol* (2019) 70:378-86. doi: 10.1016/j.intimp.2019.02.028

17. Kim S, Shin YC, Kim TY, Kim Y, Lee YS, Lee SH, et al. Mucin degrader akkermansia muciniphila accelerates intestinal stem cell-mediated epithelial development. *Gut Microbes* (2021) 13:1-20. doi: 10.1080/19490976.2021.1892441

18. Liu G, Wang B, Huang Y, Li K, Ge W, Zhang M, et al. Immune status, duodenal development, and cecal microbial diversity of 24-day-old offspring of sd rats received bacillus subtilis-cu or cuso4 during pregnancy and lactation periods. *Biol Trace Elem Res* (2019) 191:435-42. doi: 10.1007/s12011-019-1638-5

19. Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. *Nat Methods* (2013) 10:996-8. doi: 10.1038/nmeth.2604

20. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. *Nat Biotechnol* (2013) 31:814-21. doi: 10.1038/nbt.2676

21. Shi H, Yu Y, Lin D, Zheng P, Zhang P, Hu M, et al. Beta-glucan attenuates cognitive impairment *via* the gut-brain axis in diet-induced obese mice. *Microbiome* (2020) 8:143. doi: 10.1186/s40168-020-00920-y

22. Li Q, Chen H, Zhang M, Wu T, Liu R. Altered short chain fatty acid profiles induced by dietary fiber intervention regulate AMPK levels and intestinal homeostasis. *Food Funct* (2019) 10:7174-87. doi: 10.1039/C9FO01465A

23. Zhang L, Liu C, Jiang Q, Yin Y. Butyrate in energy metabolism: There is still more to learn. *Trends Endocrinol Metab* (2021) 32:159-69. doi: 10.1016/j. tem.2020.12.003

24. Hu X, Guo J, Zhao C, Jiang P, Maimai T, Yanyi L, et al. The gut microbiota contributes to the development of staphylococcus aureus-induced mastitis in mice. *ISME J* (2020) 14:1897-910. doi: 10.1038/s41396-020-0651-1

25. Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. *Annu Rev Nutr* (2002) 22:283-307. doi: 10.1146/annurev.nutr.22.011602.092259

26. Thursby E, Juge N. Introduction to the human gut microbiota. *Biochem J* (2017) 474:1823-36. doi: 10.1042/BCJ20160510

27. Wang X, Wang W, Wang L, Yu C, Zhang G, Zhu H, et al. Lentinan modulates intestinal microbiota and enhances barrier integrity in a piglet model challenged with lipopolysaccharide. *Food Funct* (2019) 10:479-89. doi: 10.1039/C8FO02438C

28. Hoffman CL, Lalsiamthara J, Aballay A. Host mucin is exploited by pseudomonas aeruginosa to provide monosaccharides required for a successful infection. *mBio* 11 (2020) 11(2): pii:mBio.00060-20. doi: 10.1128/mBio.00060-20

29. Shekels LL, Anway RE, Lin J, Kennedy MW, Garside P, Lawrence CE, et al. Coordinated Muc2 and Muc3 mucin gene expression in trichinella spiralis infection in wild-type and cytokine-deficient mice. *Dig Dis Sci* (2001) 46:1757-64. doi: 10.1023/A:1010622125040

30. Miller HR, Nawa Y. Nippostrongylus brasiliensis: intestinal goblet-cell response in adoptively immunized rats. *Exp Parasitol* (1979) 47:81-90. doi: 10.1016/0014-4894(79)90010-9

31. Else KJ, Finkelman FD. Intestinal nematode parasites, cytokines and effector mechanisms. *Int J Parasitol* (1998) 28:1145-58. doi: 10.1016/S0020-7519(98)00087-3

32. Hasnain SZ, Wang H, Ghia JE, Haq N, Deng Y, Velcich A, et al. Mucin gene deficiency in mice impairs host resistance to an enteric parasitic infection. *Gastroenterology* (2010) 138:1763-71. doi: 10.1053/j.gastro.2010.01.045

33. Lagkouvardos I, Lesker TR, Hitch TCA, Galvez EJC, Smit N, Neuhaus K, et al. Sequence and cultivation study of muribaculaceae reveals novel species, host preference, and functional potential of this yet undescribed family. *Microbiome* (2019) 7:28. doi: 10.1186/s40168-019-0637-2

34. Lopetuso LR, Scaldaferri F, Petito V, Gasbarrini A. Commensal clostridia: leading players in the maintenance of gut homeostasis. *Gut Pathog* (2013) 5:23. doi: 10.1186/1757-4749-5-23

35. Riva A, Kuzyk O, Forsberg E, Siuzdak G, Pfann C, Herbold C, et al. A fiber-deprived diet disturbs the fine-scale spatial architecture of the murine colon microbiome. *Nat Commun* (2019) 10:4366. doi: 10.1038/s41467-019-12413-0

36. Studer N, Desharnais L, Beutler M, Brugiroux S, Terrazos MA, Menin L, et al. Functional intestinal bile acid 7alpha-dehydroxylation by clostridium scindens associated with protection from clostridium difficile infection in a gnotobiotic mouse model. *Front Cell infection Microbiol* (2016) 6:191. doi: 10.3389/fcimb.2016.00019

37. Huang S, Pang D, Li X, You L, Zhao Z, Cheung PC, et al. A sulfated polysaccharide from gracilaria lemaneiformis regulates cholesterol and bile acid metabolism in high-fat diet mice. *Food Funct* (2019) 10:3224-36. doi: 10.1039/C9FO00263D

38. Sorbara MT, Littmann ER, Fontana E, Moody TU, Kohout CE, Gjonbalaj M, et al. Functional and genomic variation between human-derived isolates of lachnospiraceae reveals inter- and intra-species diversity. *Cell Host Microbe* (2020) 28:134-46.e4. doi: 10.1016/j.chom.2020.05.005

39. Yu X, Gurry T, Nguyen LTT, Richardson HS, Alm EJ. Prebiotics and community composition influence gas production of the human gut microbiota. *mBio* 11 (2020) 11(5):mBio.00217-20. doi: 10.1128/mBio.00217-20

40. Zhai R, Xue X, Zhang L, Yang X, Zhao L, Zhang C. Strain-specific anti-inflammatory properties of two akkermansia muciniphila strains on chronic colitis in mice. *Front Cell infection Microbiol* (2019) 9:239. doi: 10.3389/fcimb.2019.00239

41. Birchenough G, Schroeder BO, Backhed F, Hansson GC. Dietary destabilisation of the balance between the microbiota and the colonic mucus barrier. *Gut Microbes* (2019) 10:246-50. doi: 10.1080/19490976.2018.1513765

42. Jiminez JA, Uwiera TC, Abbott DW, Uwiera RRE, Inglis GD. Butyrate supplementation at high concentrations alters enteric bacterial communities and reduces intestinal inflammation in mice infected with citrobacter rodentium. *mSphere* 2 (2017) 2(4) pii:mSphere00243-17. doi: 10.1128/mSphere.00243-17

43. Zhang J, Chen X, Liu P, Zhao J, Sun J, Guan W, et al. Dietary clostridium butyricum induces a phased shift in fecal microbiota structure and increases the acetic acid-producing bacteria in a weaned piglet model. *J Agric Food Chem* (2018) 66:5157-66. doi: 10.1021/acs.jafc.8b01253